The longevity industry has never seen more innovation. Precision-fermented proteins, advanced peptides, biotechnology, and novel delivery systems are reshaping healthy aging. Yet many new products still fall short. Why?
In Episode #16 of the Nutricosmetics 2030 Show, Uroš Gotar, Chief Innovation Officer at TOSLA, explores a provocative idea: the future of longevity may depend less on discovering the next breakthrough ingredient but rather more on helping consumers use proven solutions consistently.
Scientific potential matters, but it does not guarantee lasting results. A product must also earn a place in consumers’ daily lives. Why do some supplements become habits while others are forgotten after a few weeks? And why is skin health emerging as a powerful entry point into healthy aging?
Gotar looks at what brands should consider before launching a new ingredient, how biotechnology can move from scientific achievement to real-world adoption, and why trust and evidence matter to the next generation of longevity brands.